Nonalcoholic steatohepatitis (NASH) is a serious and progressive liver disease affecting millions worldwide. As a more severe form of nonalcoholic fatty liver disease (NAFLD), it can lead to fibrosis, cirrhosis, and even liver failure. With the rising prevalence of NASH and a lack of FDA-approved therapies, addressing NASH management has become a top healthcare priority.
Advancements in NASH...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek